MK-677 Receptor Pharmacology — How It Works Research published in the Journal of Clinical Endocrinology & Metabolism demonstrated that MK-677 (ibutamoren) increased mean 24-hour growth hormone levels by 97% and IGF-1 le…
Read articleTesamorelin + Ipamorelin Blend Metabolism Research The tesamorelin + ipamorelin blend metabolism research landscape changed dramatically in 2024 when a Phase II metabolic study at Johns Hopkins demonstrated that dual-GH…
Read articleTesamorelin + Ipamorelin Animal vs Human Research Research conducted at the University of Arizona found that tesamorelin + ipamorelin blend animal vs human research diverges at the receptor-binding stage. Rodent GHRH re…
Read articleTesamorelin + Ipamorelin Blend Downstream Effects Most peptide combinations produce additive effects. One mechanism plus another. The tesamorelin + ipamorelin blend is different: it creates a synergistic hormonal cascad…
Read articleTesamorelin + Ipamorelin Blend Bioavailability Explained Research conducted at Massachusetts General Hospital found that tesamorelin achieves 100% bioavailability when administered subcutaneously, while ipamorelin reach…
Read articleTesamorelin + Ipamorelin Blend Gene Expression — Effects A 2023 study published in the Journal of Clinical Endocrinology & Metabolism found that combined growth hormone secretagogue therapy altered expression of more th…
Read articleTesamorelin + Ipamorelin Blend Biomarkers — What to Track The tesamorelin + ipamorelin blend biomarkers most practitioners track. IGF-1, fasting glucose, visceral adipose tissue (VAT). Don't tell the full story. A patie…
Read articleTesamorelin + Ipamorelin Blend Receptor Pharmacology A 2019 study published in the Journal of Clinical Endocrinology & Metabolism found that combining GHRH analogues with ghrelin mimetics produced 3.2× higher peak GH re…
Read articleTesamorelin + Ipamorelin Blend Primary Pathway Mechanism A 2019 study published in the Journal of Clinical Endocrinology & Metabolism found that combined GHRH and ghrelin receptor agonism produced 1.8× greater peak GH a…
Read articleTesamorelin + Ipamorelin Blend Pharmacokinetics — Real Peptides Research from the University of Virginia School of Medicine found that tesamorelin + ipamorelin blend pharmacokinetics produce a biphasic growth hormone re…
Read articleTesamorelin + Ipamorelin Blend Signaling Pathway Explained Research from the Pennington Biomedical Research Center demonstrated that tesamorelin monotherapy reduced visceral adipose tissue (VAT) by 15.2% over 26 weeks. …
Read articleTesamorelin Metabolism Research — Growth Hormone Mechanisms A 2020 study published in The Journal of Clinical Endocrinology & Metabolism found that HIV-positive patients treated with 2mg daily tesamorelin for 26 weeks e…
Read articleTesamorelin Pharmacokinetics — Absorption, Half-Life & Clearance Tesamorelin hydrochloride isn't stored in fat tissue waiting to slowly release into circulation over days. It enters circulation rapidly, peaks within 15 …
Read articleCJC-1295 No DAC & Ipamorelin Metabolism Research Research published in the Journal of Clinical Endocrinology & Metabolism found that CJC-1295 No DAC (also termed modified GRF 1-29) extends the amplitude of growth hormon…
Read articleCJC-1295 No DAC & Ipamorelin Animal vs Human Research Research on CJC-1295 no DAC and ipamorelin is dominated by animal models. Not human subjects. A systematic review of published peptide studies through 2025 reveals t…
Read articleCJC-1295 No DAC & Ipamorelin Bioavailability — Absorption Facts A 2019 pharmacokinetic study published in the Journal of Clinical Endocrinology & Metabolism found that subcutaneous CJC-1295 no DAC achieved 92% systemic …
Read articleCJC-1295 No DAC & Ipamorelin Gene Expression Effects A 2019 study published in the Journal of Clinical Endocrinology & Metabolism found that growth hormone secretagogues don't just trigger acute GH release. They upregul…
Read articleCJC-1295 No DAC & Ipamorelin Receptor Pharmacology The most misunderstood aspect of growth hormone secretagogues isn't the dosing schedule or reconstitution protocol. It's the receptor-level mechanism that determines wh…
Read articleCJC-1295 No DAC & Ipamorelin Downstream Effects Explained CJC-1295 no DAC (drug affinity complex) and ipamorelin aren't just growth hormone secretagogues. They're upstream modulators of a biological cascade that extends…
Read articleCJC-1295 No DAC & Ipamorelin Signaling Pathway Explained A 2019 study published in the Journal of Clinical Endocrinology & Metabolism found that combining GHRH analogs with ghrelin mimetics produced GH secretion amplitu…
Read article